Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease

BACKGROUND: We here examined whether plasma desmosterol-to-cholesterol ratio (DES/CHO) is decreased in patients with Alzheimer's disease (AD) and investigated the association between plasma DES/CHO and longitudinal cognitive decline. METHODS: Plasma DES/CHO of AD patients and age-matched contro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Sato, Yoshiaki, Bernier, Francois, Yamanaka, Yasukazu, Aoshima, Ken, Oda, Yoshiya, Ingelsson, Martin, Lannfelt, Lars, Miyashita, Akinori, Kuwano, Ryozo, Ikeuchi, Takeshi
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2015
Matèries:
Blood-Based Biomarker
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876914/
https://ncbi.nlm.nih.gov/pubmed/27239493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2014.11.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars